ACCESSION: MSBNK-SMB_Measured-HSA001P0139003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 62
COMMENT: RAW_SPEC {'BLK01_10670': {'bp': 1256368.0, 'sum': 2322272.0}, 'BLK01_10733': {'bp': 1043533.0, 'sum': 1930676.0}, 'BLK01_10797': {'bp': 1007239.0, 'sum': 1885128.0}, 'BLK01_10860': {'bp': 815878.0, 'sum': 1526227.0}, 'BLK02_10606': {'bp': 734778.0, 'sum': 1329259.0}, 'BLK01_10923': {'bp': 705859.0, 'sum': 1360210.0}, 'ProcedureBlank_10607': {'bp': 695236.0, 'sum': 1201798.0}, 'BLK01_10986': {'bp': 650233.0, 'sum': 1241630.0}, 'BLK02_10669': {'bp': 571285.0, 'sum': 1030873.0}, 'ProcedureBlank_10670': {'bp': 537239.0, 'sum': 990103.0}, '1_posi_10629': {'bp': 503807.0, 'sum': 893886.0}, 'BLK01_11050': {'bp': 493838.0, 'sum': 976357.0}, 'BLK02_10732': {'bp': 443655.0, 'sum': 811917.0}, '1_posi_10692': {'bp': 416895.0, 'sum': 794762.0}, 'BLK01_11114': {'bp': 405404.0, 'sum': 834844.0}, '2_posi_10613': {'bp': 398700.0, 'sum': 703717.0}, 'ProcedureBlank_10733': {'bp': 393656.0, 'sum': 730687.0}, 'BLK01_11177': {'bp': 381477.0, 'sum': 805992.0}, 'BLK01_11240': {'bp': 337139.0, 'sum': 729016.0}, '1_posi_10757': {'bp': 329281.0, 'sum': 629415.0}, '2_posi_10675': {'bp': 310930.0, 'sum': 602663.0}, '4_posi_10609': {'bp': 299904.0, 'sum': 588246.0}, 'ProcedureBlank_10799': {'bp': 298242.0, 'sum': 561453.0}, 'BLK01_11303': {'bp': 288900.0, 'sum': 672684.0}, 'BLK02_10795': {'bp': 287453.0, 'sum': 553637.0}, '3_posi_10653': {'bp': 276814.0, 'sum': 549609.0}, '1_posi_10823': {'bp': 264737.0, 'sum': 564194.0}, '4_posi_10672': {'bp': 264201.0, 'sum': 514948.0}, 'BLK01_11366': {'bp': 246962.0, 'sum': 606875.0}, 'BLK02_10859': {'bp': 243431.0, 'sum': 504668.0}, '6_posi_10631': {'bp': 233427.0, 'sum': 446712.0}, '5_posi_10631': {'bp': 233090.0, 'sum': 446975.0}, '3_posi_10718': {'bp': 231965.0, 'sum': 495630.0}, '4_posi_10739': {'bp': 223557.0, 'sum': 491165.0}, '7_posi_10595': {'bp': 220155.0, 'sum': 468688.0}, 'ProcedureBlank_10864': {'bp': 216945.0, 'sum': 452611.0}, '2_posi_10738': {'bp': 208040.0, 'sum': 441282.0}, '9_posi_10613': {'bp': 185548.0, 'sum': 415538.0}, '8_posi_10657': {'bp': 181847.0, 'sum': 391972.0}, '3_posi_10781': {'bp': 174884.0, 'sum': 378914.0}, '5_posi_10698': {'bp': 174682.0, 'sum': 388344.0}, '1_posi_10886': {'bp': 173686.0, 'sum': 398648.0}, '2_posi_10800': {'bp': 170120.0, 'sum': 422926.0}, '4_posi_10803': {'bp': 163523.0, 'sum': 416404.0}, '7_posi_10659': {'bp': 163078.0, 'sum': 353443.0}, '10_posi_10635': {'bp': 161515.0, 'sum': 392588.0}, '11_posi_10635': {'bp': 161435.0, 'sum': 416066.0}, 'ProcedureBlank_10928': {'bp': 161428.0, 'sum': 377196.0}, '6_posi_10697': {'bp': 159786.0, 'sum': 376869.0}, '13_posi_10595': {'bp': 159366.0, 'sum': 400983.0}, 'BLK02_10922': {'bp': 158053.0, 'sum': 382772.0}, '14_posi_10613': {'bp': 156144.0, 'sum': 406069.0}, '1_posi_10951': {'bp': 154089.0, 'sum': 388567.0}, '10_posi_10698': {'bp': 148451.0, 'sum': 395120.0}, '16_posi_10634': {'bp': 146994.0, 'sum': 386947.0}, '9_posi_10677': {'bp': 142107.0, 'sum': 355113.0}, '8_posi_10721': {'bp': 140259.0, 'sum': 362652.0}, '9_posi_10740': {'bp': 138544.0, 'sum': 346232.0}, '5_posi_10761': {'bp': 134574.0, 'sum': 351397.0}, '7_posi_10738': {'bp': 128514.0, 'sum': 319322.0}, '6_posi_10760': {'bp': 126810.0, 'sum': 353667.0}, '3_posi_10843': {'bp': 125332.0, 'sum': 324810.0}}
COMMENT: RETENTION_TIME_STDEV 0.340
COMMENT: PRECURSOR_M/Z_RAW 139.122620
COMMENT: PRECURSOR_M/Z_STDEV 0.000051
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.087; C8H14N2; [M+H]+; delta(ppm) -0.086884
COMMENT: PROPOSED_MF MS-FINDER 3.103; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.071; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.239; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.618; AIUVAZQMVWSJEN-UHFFFAOYSA-N; [M+H]+; N1=C(C=C(N1C(C)C)C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.610; FPLOWPOUHNRUMN-UHFFFAOYSA-N; [M+H]+; CCC(CC)C1=NC=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.433; RLEMOPKSUBPPLL-UHFFFAOYSA-N; [M+H]+; N1=C(C(=C(N1C)C)C)CC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.007; AIUVAZQMVWSJEN-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.799; RLEMOPKSUBPPLL-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.729; FPLOWPOUHNRUMN-UHFFFAOYSA-N; [M+H]+; 2-pentan-3-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RLEMOPKSUBPPLL-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.983; AIUVAZQMVWSJEN-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.957; FPLOWPOUHNRUMN-UHFFFAOYSA-N; [M+H]+; 2-pentan-3-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.546; UPYVYJSWGZMBOU-UHFFFAOYSA-N; [M+H]+; 1-pentylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.395; WHLZPGRDRYCVRQ-UHFFFAOYSA-N; [M+H]+; 1-butyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.156; YZICFVIUVMCCOC-UHFFFAOYSA-N; [M+H]+; 3-piperidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.918; DSMAHJDZYJDGTD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.643; OSDDDHPYSNZBPF-UHFFFAOYSA-N; [M+H]+; 4-pyrrolidin-1-ylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.621; SVNWKKJQEFIURY-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(2-methylpropyl)imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; JCLLVTBCUGMKAT-UHFFFAOYSA-N; [M+H]+; 3-piperidin-2-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.284; GIZMBLLDGLCEQX-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.283; ACOLJMMCKXMANR-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpiperidin-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.279; OHKGIEVCPHMZKY-UHFFFAOYSA-N; [M+H]+; 2-(azepan-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.260; RDTAATZMSHBUDM-UHFFFAOYSA-N; [M+H]+; 4-ethylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.257; GTEKSPGKRFEHRA-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; YHGZCPAPXDXHCY-UHFFFAOYSA-N; [M+H]+; 3-(cyclopentylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.247; ZNKPVILXADENLY-UHFFFAOYSA-N; [M+H]+; (1-propylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.241; PXLWBYQKAOCCHM-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-2,6-diazaspiro[3.3]heptane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.236; CWTWISUHUSOWMU-UHFFFAOYSA-N; [M+H]+; 3-amino-1-methylcyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.232; NOXAORINZJERRC-UHFFFAOYSA-N; [M+H]+; 1-methyl-4-prop-2-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.228; GUGMWCUXIGSRJX-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.220; OEVYDWMZOGZKIJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-(propan-2-ylamino)but-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.213; MIJYJUOXVFSADM-QMMMGPOBSA-N; [M+H]+; [(2S)-1-prop-2-ynylpyrrolidin-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.209; LPAIJTCPOYPLDO-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.206; OITIWHCOLGQTAF-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-3,3-dimethylcyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.197; PIXBBFRQUKVNLN-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.193; ZFXSRXFFVQUSJG-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.192; PAQTZJCQRHONNN-UHFFFAOYSA-N; [M+H]+; 1-(1-ethylpyrrol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.185; UZHJWWNKUFBJHO-UHFFFAOYSA-N; [M+H]+; 2-(1-ethylpyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.174; FOILTVVMJVTRIH-UHFFFAOYSA-N; [M+H]+; 1-amino-4-methylcyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.137; ZWKWOOLQWOHHSL-UHFFFAOYSA-N; [M+H]+; 1-but-3-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.128; CBRUYTAKOYULDK-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclohexylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.116; OLUSMJNIPLCWBR-UHFFFAOYSA-N; [M+H]+; N-prop-2-ynylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; MTLXTAIUWACVSW-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrrol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; FKYWLZUPBICXFW-UHFFFAOYSA-N; [M+H]+; 4,9-diazatricyclo[5.3.0.02,6]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.081; QXPUWXJUGPMKRK-UHFFFAOYSA-N; [M+H]+; bicyclo[2.2.1]heptane-2-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.074; QDKVKIHUOVMMCG-UHFFFAOYSA-N; [M+H]+; (1,2,5-trimethylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.071; AQVCJKMGVKNXCB-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.055; SSXMIBAFANQRTR-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.042; PUKVGBPMTQRQGP-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(1H-pyrrol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -93.814; OHKGIEVCPHMZKY; [M+H]+; 1-Azepanylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -98.327; OSDDDHPYSNZBPF; [M+H]+; 1-Pyrrolidinebutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -114.566; YZICFVIUVMCCOC; [M+H]+; Piperidinopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -146.804; ZFXSRXFFVQUSJG; [M+H]+; 1-(aminomethyl)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.292; NOXAORINZJERRC; [M+H]+; 1-Methyl-4-prop-2-ynyl-piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.912; YHGZCPAPXDXHCY; [M+H]+; 3-(Cyclopentylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.729; PXLWBYQKAOCCHM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.432; DSMAHJDZYJDGTD; [M+H]+; (1-cyanocyclohexyl)-methylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.481; WHLZPGRDRYCVRQ; [M+H]+; 1-butyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.158; IQQRAVYLUAZUGX; [M+H]+; [bmim]
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.523; UPYVYJSWGZMBOU; [M+H]+; 1-pentylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.204; AIUVAZQMVWSJEN; [M+H]+; 3,5-dimethyl-1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.739; RLEMOPKSUBPPLL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -318.896; AQVCJKMGVKNXCB; [M+H]+; 2-Dimethylaminomethyl-1-methylpyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -341.256; FPLOWPOUHNRUMN; [M+H]+; 2-pentan-3-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.306; OHKGIEVCPHMZKY; [M+H]+; 1-Azepanylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -80.163; OSDDDHPYSNZBPF; [M+H]+; 1-Pyrrolidinebutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.279; NOXAORINZJERRC; [M+H]+; 1-Methyl-4-(prop-2-yn-1-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -104.319; OHKGIEVCPHMZKY; [M+H]+; Hexahydro-1H-azepine-1-acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -112.090; RINRSJBJOGCGBE; [M+H]+; 2,2,5,6-Tetramethyl-2,3-dihydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.435; GUGMWCUXIGSRJX; [M+H]+; 3,3-Dideuterio-2-methyl-2-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.637; YZICFVIUVMCCOC; [M+H]+; Hydron;3-piperidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.960; PXLWBYQKAOCCHM; [M+H]+; 2-Cyclopropyl-2,6-diazaspiro[3.3]heptane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.641; YHGZCPAPXDXHCY; [M+H]+; 3-(Cyclopentylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -167.195; LPAIJTCPOYPLDO; [M+H]+; (3S)-1-prop-2-ynylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.071; DSMAHJDZYJDGTD; [M+H]+; (1-Cyanocyclohexyl)-methylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.343; OSDDDHPYSNZBPF; [M+H]+; 1-Pyrrolidinebutanenitrile
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C8H15N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 21.615
MS$FOCUSED_ION: PRECURSOR_M/Z 139.122962
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-2900000000-004203aaeec8dabed426
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  69.0334044 45.4401 69.034030 1.5500 26.78 -0.3614 62 ?
  69.0697746 34.7980 69.070400 1.6795 19.03 0.1100 62 f{C5H9}/-1.48ppm,p-C3H6N2
  70.0650705 24.0388 70.065690 1.7698 7.71 0.9017 51 f{C4H8N1}/-0.79ppm,p-C4H7N1
  81.0697739 25.0526 81.070300 1.7269 10.27 0.6693 59 f{C6H9}/-1.27ppm,p-C2H6N2
  83.0491112 68.1655 83.049615 1.4449 38.86 -0.4274 62 ?
  93.0698463 39.6885 93.070220 1.5150 22.72 -0.1641 62 f{C7H9}/-0.33ppm,p-C1H6N2
  95.0854903 19.9497 95.085850 2.0298 9.05 0.1386 45 f{C7H11}/-0.38ppm,p-C1H4N2
  96.0807276 24.5616 96.081080 1.4779 7.73 0.8802 47 f{C6H10N1}/-0.50ppm,p-C2H5N1
  97.0649149 24.2299 97.065260 2.3695 11.10 0.2176 55 ?
  97.0760650 115.4753 97.076410 0.9065 44.85 0.9578 62 f{C5H9N2}/0.42ppm,p-C3H6
  98.0964579 82.3565 98.096795 0.8461 27.27 0.9315 62 f{C6H12N1}/0.33ppm,p-C2H3N1
  111.0917444 99.1597 111.091960 0.9002 28.77 0.9529 62 f{C6H11N2}/0.63ppm,p-C2H4
  121.1011346 51.9717 121.101230 1.7919 29.12 -0.4184 62 ?
  139.0502301 44.9336 139.050135 1.5246 19.66 0.5592 62 ?
  139.0866851 56.3374 139.086590 1.3373 27.67 0.3524 61 ?
  139.0983051 56.7093 139.098210 2.1639 25.57 0.1468 58 ?
  139.1118051 198.4496 139.111710 1.7324 96.19 -0.3058 59 ?
  139.1229701 999.0000 139.122875 1.1716 0.00 1.0000 62 f{C8H15N2}/-0.03ppm,p
PK$NUM_PEAK: 18
PK$PEAK: m/z int. rel.int.
  69.033404 45.44 45
  69.069775 34.80 34
  70.065070 24.04 24
  81.069774 25.05 25
  83.049111 68.17 68
  93.069846 39.69 39
  95.085490 19.95 19
  96.080728 24.56 24
  97.064915 24.23 24
  97.076065 115.48 115
  98.096458 82.36 82
  111.091744 99.16 99
  121.101135 51.97 51
  139.050230 44.93 44
  139.086685 56.34 56
  139.098305 56.71 56
  139.111805 198.45 198
  139.122970 999.00 999
//
